Global Biologics Market Research Report 2023(Status and Outlook)
Report Overview
A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA.
North America dominated with respect to revenue generation owing to the presence of significant established participants in this region. Moreover, higher demand for the products for treatment of diseases is attributive for larger revenue share.
The Global Biologics Market Size was estimated at USD 104160 million in 2022 and is projected to reach USD 148528.96 million by 2029, exhibiting a CAGR of 5.20% during the forecast period.
Bosson Research’s latest report provides a deep insight into the global Biologics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Biologics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Biologics market in any manner.
Global Biologics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Eli Lilly & Company
Samsung Biologics
F Hoffman La Roche
Celltrion
Addgene
Amgen
Abbvie Inc.
Sanofi
Pfizer Inc.
Merck & Co. Inc.
Novo Nordisk A/S
Johnson & Johnson Services Inc.
Market Segmentation (by Type)
Monoclonal Antibodies
Vaccines
Recombinant Proteins
Antisense
RNAi
Market Segmentation (by Application)
Alcohol
Food and Beverages
Construction
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Biologics Market
Overview of the regional outlook of the Biologics Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Biologics
- 1.2 Key Market Segments
- 1.2.1 Biologics Segment by Type
- 1.2.2 Biologics Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Biologics Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Biologics Market Size (M USD) Estimates and Forecasts (2018-2029)
- 2.1.2 Global Biologics Sales Estimates and Forecasts (2018-2029)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 Biologics Market Competitive Landscape
- 3.1 Global Biologics Sales by Manufacturers (2018-2023)
- 3.2 Global Biologics Revenue Market Share by Manufacturers (2018-2023)
- 3.3 Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.4 Global Biologics Average Price by Manufacturers (2018-2023)
- 3.5 Manufacturers Biologics Sales Sites, Area Served, Product Type
- 3.6 Biologics Market Competitive Situation and Trends
- 3.6.1 Biologics Market Concentration Rate
- 3.6.2 Global 5 and 10 Largest Biologics Players Market Share by Revenue
- 3.6.3 Mergers & Acquisitions, Expansion
- 4 Biologics Industry Chain Analysis
- 4.1 Biologics Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Biologics Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Market Restraints
- 5.5 Industry News
- 5.5.1 New Product Developments
- 5.5.2 Mergers & Acquisitions
- 5.5.3 Expansions
- 5.5.4 Collaboration/Supply Contracts
- 5.6 Industry Policies
- 6 Biologics Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Biologics Sales Market Share by Type (2018-2023)
- 6.3 Global Biologics Market Size Market Share by Type (2018-2023)
- 6.4 Global Biologics Price by Type (2018-2023)
- 7 Biologics Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Biologics Market Sales by Application (2018-2023)
- 7.3 Global Biologics Market Size (M USD) by Application (2018-2023)
- 7.4 Global Biologics Sales Growth Rate by Application (2018-2023)
- 8 Biologics Market Segmentation by Region
- 8.1 Global Biologics Sales by Region
- 8.1.1 Global Biologics Sales by Region
- 8.1.2 Global Biologics Sales Market Share by Region
- 8.2 North America
- 8.2.1 North America Biologics Sales by Country
- 8.2.2 U.S.
- 8.2.3 Canada
- 8.2.4 Mexico
- 8.3 Europe
- 8.3.1 Europe Biologics Sales by Country
- 8.3.2 Germany
- 8.3.3 France
- 8.3.4 U.K.
- 8.3.5 Italy
- 8.3.6 Russia
- 8.4 Asia Pacific
- 8.4.1 Asia Pacific Biologics Sales by Region
- 8.4.2 China
- 8.4.3 Japan
- 8.4.4 South Korea
- 8.4.5 India
- 8.4.6 Southeast Asia
- 8.5 South America
- 8.5.1 South America Biologics Sales by Country
- 8.5.2 Brazil
- 8.5.3 Argentina
- 8.5.4 Columbia
- 8.6 Middle East and Africa
- 8.6.1 Middle East and Africa Biologics Sales by Region
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Egypt
- 8.6.5 Nigeria
- 8.6.6 South Africa
- 9 Key Companies Profile
- 9.1 Eli Lilly andamp; Company
- 9.1.1 Eli Lilly andamp; Company Biologics Basic Information
- 9.1.2 Eli Lilly andamp; Company Biologics Product Overview
- 9.1.3 Eli Lilly andamp; Company Biologics Product Market Performance
- 9.1.4 Eli Lilly andamp; Company Business Overview
- 9.1.5 Eli Lilly andamp; Company Biologics SWOT Analysis
- 9.1.6 Eli Lilly andamp; Company Recent Developments
- 9.2 Samsung Biologics
- 9.2.1 Samsung Biologics Biologics Basic Information
- 9.2.2 Samsung Biologics Biologics Product Overview
- 9.2.3 Samsung Biologics Biologics Product Market Performance
- 9.2.4 Samsung Biologics Business Overview
- 9.2.5 Samsung Biologics Biologics SWOT Analysis
- 9.2.6 Samsung Biologics Recent Developments
- 9.3 F Hoffman La Roche
- 9.3.1 F Hoffman La Roche Biologics Basic Information
- 9.3.2 F Hoffman La Roche Biologics Product Overview
- 9.3.3 F Hoffman La Roche Biologics Product Market Performance
- 9.3.4 F Hoffman La Roche Business Overview
- 9.3.5 F Hoffman La Roche Biologics SWOT Analysis
- 9.3.6 F Hoffman La Roche Recent Developments
- 9.4 Celltrion
- 9.4.1 Celltrion Biologics Basic Information
- 9.4.2 Celltrion Biologics Product Overview
- 9.4.3 Celltrion Biologics Product Market Performance
- 9.4.4 Celltrion Business Overview
- 9.4.5 Celltrion Biologics SWOT Analysis
- 9.4.6 Celltrion Recent Developments
- 9.5 Addgene
- 9.5.1 Addgene Biologics Basic Information
- 9.5.2 Addgene Biologics Product Overview
- 9.5.3 Addgene Biologics Product Market Performance
- 9.5.4 Addgene Business Overview
- 9.5.5 Addgene Biologics SWOT Analysis
- 9.5.6 Addgene Recent Developments
- 9.6 Amgen
- 9.6.1 Amgen Biologics Basic Information
- 9.6.2 Amgen Biologics Product Overview
- 9.6.3 Amgen Biologics Product Market Performance
- 9.6.4 Amgen Business Overview
- 9.6.5 Amgen Recent Developments
- 9.7 Abbvie Inc.
- 9.7.1 Abbvie Inc. Biologics Basic Information
- 9.7.2 Abbvie Inc. Biologics Product Overview
- 9.7.3 Abbvie Inc. Biologics Product Market Performance
- 9.7.4 Abbvie Inc. Business Overview
- 9.7.5 Abbvie Inc. Recent Developments
- 9.8 Sanofi
- 9.8.1 Sanofi Biologics Basic Information
- 9.8.2 Sanofi Biologics Product Overview
- 9.8.3 Sanofi Biologics Product Market Performance
- 9.8.4 Sanofi Business Overview
- 9.8.5 Sanofi Recent Developments
- 9.9 Pfizer Inc.
- 9.9.1 Pfizer Inc. Biologics Basic Information
- 9.9.2 Pfizer Inc. Biologics Product Overview
- 9.9.3 Pfizer Inc. Biologics Product Market Performance
- 9.9.4 Pfizer Inc. Business Overview
- 9.9.5 Pfizer Inc. Recent Developments
- 9.10 Merck andamp; Co. Inc.
- 9.10.1 Merck andamp; Co. Inc. Biologics Basic Information
- 9.10.2 Merck andamp; Co. Inc. Biologics Product Overview
- 9.10.3 Merck andamp; Co. Inc. Biologics Product Market Performance
- 9.10.4 Merck andamp; Co. Inc. Business Overview
- 9.10.5 Merck andamp; Co. Inc. Recent Developments
- 9.11 Novo Nordisk A/S
- 9.11.1 Novo Nordisk A/S Biologics Basic Information
- 9.11.2 Novo Nordisk A/S Biologics Product Overview
- 9.11.3 Novo Nordisk A/S Biologics Product Market Performance
- 9.11.4 Novo Nordisk A/S Business Overview
- 9.11.5 Novo Nordisk A/S Recent Developments
- 9.12 Johnson andamp; Johnson Services Inc.
- 9.12.1 Johnson andamp; Johnson Services Inc. Biologics Basic Information
- 9.12.2 Johnson andamp; Johnson Services Inc. Biologics Product Overview
- 9.12.3 Johnson andamp; Johnson Services Inc. Biologics Product Market Performance
- 9.12.4 Johnson andamp; Johnson Services Inc. Business Overview
- 9.12.5 Johnson andamp; Johnson Services Inc. Recent Developments
- 10 Biologics Market Forecast by Region
- 10.1 Global Biologics Market Size Forecast
- 10.2 Global Biologics Market Forecast by Region
- 10.2.1 North America Market Size Forecast by Country
- 10.2.2 Europe Biologics Market Size Forecast by Country
- 10.2.3 Asia Pacific Biologics Market Size Forecast by Region
- 10.2.4 South America Biologics Market Size Forecast by Country
- 10.2.5 Middle East and Africa Forecasted Consumption of Biologics by Country
- 11 Forecast Market by Type and by Application (2024-2029)
- 11.1 Global Biologics Market Forecast by Type (2024-2029)
- 11.1.1 Global Forecasted Sales of Biologics by Type (2024-2029)
- 11.1.2 Global Biologics Market Size Forecast by Type (2024-2029)
- 11.1.3 Global Forecasted Price of Biologics by Type (2024-2029)
- 11.2 Global Biologics Market Forecast by Application (2024-2029)
- 11.2.1 Global Biologics Sales (K MT) Forecast by Application
- 11.2.2 Global Biologics Market Size (M USD) Forecast by Application (2024-2029)
- 12 Conclusion and Key Findings
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook